Novus Therapeutics Inc (NASDAQ:NVUS), a USD$29.55M small-cap, operates in the healthcare industry, which has experienced tailwinds from issues such as higher demand driven by an aging population and ...
CALGARY , Feb. 3 /CNW/ - Novus Energy Inc. ("Novus" or the "Company") (TSXV: NVS) is pleased to announce that it has entered into an agreement (the "Amalgamation Agreement") whereby, subject to ...
IRVINE, Calif.--(BUSINESS WIRE)-- Novus Therapeutics, Inc. (“Novus”) (NASDAQ: NVUS), a clinical stage biopharmaceutical company focused on developing life-changing, targeted medicines for patients ...
Novus Therapeutics Inc (NASDAQ:NVUS) continues its loss-making streak, announcing a -$6.28M earnings for its latest financial year ending. Cash is crucial to run a business, and if a company burns ...
IRVINE, Calif.--(BUSINESS WIRE)--Novus Therapeutics, Inc. (“Novus”) (NASDAQ: NVUS), a clinical stage biopharmaceutical company focused on developing life-changing, targeted medicines for patients ...
Novus currently has 19 wells licensed in the Whiteside, Flaxcombe, Kerrobert and Dodsland areas of Saskatchewan (the "Greater Dodsland Area"). Of the 19 well licenses presently issued, 17 are licensed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results